期刊文献+

高剂量左氧氟沙星治疗老年呼吸道感染的临床研究 被引量:4

下载PDF
导出
摘要 目的观察高剂量左氧氟沙量静滴治疗老年呼吸道感染的安全性与有效性。方法对70例老年呼吸道感染患者分为高剂量左氧氟沙量(可乐必妥)500mg/d-次静脉滴注的治疗组和头孢曲松2g/次,每天两次静脉滴注的对照组,疗程5~10d后进行治疗前后两组间的比较。结果治疗组和对照组的临床总有效率分别为91%和89%。经统计学处理差异无显著性,不良反应发生率两组间无统计学意义。结论高剂量左氧氟沙星治疗老年呼吸道感染疗效良好,副作用较少,是治疗轻中度老年呼吸道感染较理想的药物。
出处 《临床肺科杂志》 2008年第5期654-654,656,共2页 Journal of Clinical Pulmonary Medicine
  • 相关文献

参考文献6

  • 1File TM, new insights in the traetmeat by levofloxacin. Chemotherapy, 2004,50( suppl 1 ) :22 - 28.
  • 2Fish DN, Levofloxacin :Update and perspective on one of the original "respiratory quinolones ", Exp Revi Anti insect Ther,2003,1 ( 3 ) :371 - 387.
  • 3Hospital-aquired pnoumonia guideline committee of the American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, and healthcare-associated pneumonia. Am J Respir Crit careMed, 2005,171:388 -416.
  • 4社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3052
  • 5黄绍光,肖伟,梁瑛,朱惠莉,张德平,陈正贤,李建国.高剂量左氧氟沙星静脉制剂治疗呼吸道感染的临床研究[J].国际呼吸杂志,2006,26(4):241-244. 被引量:23
  • 6Hurst M, Lamb HM, scott LJ, et al, levofloxacin : An updated review of its use in the treatment of bacterial infections. Drugs,2002,62(14) : 2127 -2167.

二级参考文献31

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 3File TM,Segreti J,Dunbar L,et al.A multicenter,randomized study comparing the safety of intravenous and /or oral levofloxacin versus ceftriaxone an d/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia.Antimicrob Agents Chemother,1997,41(9):1965-1972.
  • 4Marrie TJ.Experience with levofloxacin in critical pathway for the treatment of community-acquired pneumonia.Chemotherapy,2004,50 (Suppl 1) 11-15.
  • 5Frank E,Liu J,Kinasewitz G,et al.A multicenter open-label,randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia.Clin Ther,2002,24 (8):1292-1308.
  • 6Mandell LA,Bartlett JG,Dowell SF,et al.Infectious Diseases Society of America.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37 (5):1405-1433.
  • 7Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America.Clin Infect Dis,2000,31(2):347-382.
  • 8Ball P.Efficacy and safety of levofloxacin in the context of other contemporary fluroquinolones:A review.Cur Therapeutic Res,2003,64(9):646-661.
  • 9Hurst M,Lamb HM,Scott LJ,et al.Levofloxacin:An updated review of its use in the treatment of bacterial infections.Drugs,2002,62(14):2127-2167.
  • 10Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.

共引文献3072

同被引文献32

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部